Influenza Vaccines Contracts Visual Aid.pdf

This document illustrates the MMCAP Infuse Flu Vaccine Access network, which appears to be a contract vehicle facilitating flu vaccine procurement for MMCAP Infuse Members. The network involves multiple pharmaceutical manufacturers including Sanofi Pasteur, Seqirus, GlaxoSmithKline, and AstraZeneca, along with various distributors and specialty healthcare companies such as Cardinal Health, AmerisourceBergen, Morris & Dickson, ASD Specialty Healthcare, FFF Enterprises, and McKesson Med-Surg. The diagram shows interconnected relationships between these entities through contract identification numbers and website references.

The contract covers various flu vaccine products including Flublok, Fluzone, and Fluzone HD from Sanofi Pasteur; Afluria, Fluad, and Flucelvax from Seqirus; Fluarix and FluLaval from GlaxoSmithKline; and FluMist from AstraZeneca. The pricing structure operates under two distinct models: dotted lines indicate "no chargeback" arrangements where pricing is determined by the seller rather than through MMCAP Infuse contract terms, while solid lines represent "chargebacks allowed" arrangements where MMCAP Infuse contract pricing is passed through to members. This dual pricing approach provides flexibility in how vaccine costs are structured and administered across the network participants.